Acerus Pharmaceuticals, Aytu deal

Acerus (formerly Trimel Pharmaceuticals Corp.) granted Aytu exclusive, U.S. marketing rights

Read the full 118 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE